Madridge Journal of Vaccines

ISSN: 2638-1966

Accepted Abstracts

International Conference on Vaccines
Feb 20-22, 2017, Baltimore, USA

A novel vaccine strategy against pneumococcal disease based on virulence determinants not expressed during colonization

Madridge J Vaccines. 2017

DOI: 10.18689/2638-1966.a1.004

Author(s): Anders P. Hakansson, Terry D. Connell, Charles H. Jones and Blaine A. Pfeifer

Establishing micro-neutralization assays for human viruses using a quantitative PCR endpoint

Madridge J Vaccines. 2017

DOI: 10.18689/2638-1966.a1.004

Author(s): Li Sheng-Fowler, Stella Lee, Kathryn Phy and Keith Peden

The vaccine candidate Vibrio cholerae 638, was safe and immunogenic in healthy children and adolescents, from Cienfuegos province, Cuba

Madridge J Vaccines. 2017

DOI: 10.18689/2638-1966.a1.004

Author(s): Hilda García, Rodrigo Valera, Rafael Fando, Jorge Pérez Jr, Elida Cardoso, Marlen Armesto, Mayelin Mirabal, Barbara Cedre, Talena Ledon, Karen Marrero, Rossana Estruch, Luis Gracía, Concepción Campa, Francisco Domínguez and Jorge Pérez

Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus

Madridge J Vaccines. 2017

DOI: 10.18689/2638-1966.a1.004

Author(s): H. A. Hussein, B. M. Ahmed, S. M. Aly, A. H. El-Deeb, A. A. El-Sanousi, M. A. Rohaim, A. A. Arafa and M. R. Gadalla

Investigating HIV-1 induced immune activation mechanism and potential therapeutic approaches in humanized NSG mice model

Madridge J Vaccines. 2017

DOI: 10.18689/2638-1966.a1.004

Author(s): Maneesh Singh, Pratibha Singh, Dolores Vaira and Michel Moutschen

A novel vaccine construct comprising of lipidated peptide protects against Mycobacterium tuberculosis by bolstering enduring memory T cell response

Madridge J Vaccines. 2017

DOI: 10.18689/2638-1966.a1.004

Author(s): Javed N Agrewala, Pradeep K Rai, Sajid Nadeem, Weiguang Zeng, Ashok K Janmeja and David C Jackson